Pinto Shelly 4
4 · ALX ONCOLOGY HOLDINGS INC · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
ALX Oncology SVP Shelly Pinto Sells 903 Shares
What Happened
Shelly Pinto, SVP, Finance and CAO of ALX Oncology Holdings Inc. (ALXO), sold 903 shares on 2026-03-19 at $2.17 per share, for total proceeds of $1,960. The filing indicates the shares were sold to satisfy tax withholding obligations related to the vesting of performance-based restricted stock units — a routine, non-directional transaction.
Key Details
- Transaction date: 2026-03-19; Price: $2.17 per share; Shares sold: 903; Proceeds: $1,960.
- Transaction type: Sale (S) — open market or private sale.
- Footnote: Sale was to satisfy tax obligations in connection with vesting of performance-based RSUs.
- Shares owned after transaction: Not disclosed in this Form 4.
- Filing date: 2026-03-23 — filing appears timely (within the usual 2 business-day window).
Context
Tax-withholding sales after RSU vesting are common and generally reflect routine obligations rather than an insider expressing a bearish view. For retail investors, outright purchases are typically more informative about insider sentiment; this transaction should be viewed as administrative in nature.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-19$2.17/sh−903$1,960→ 86,805 total
Footnotes (1)
- [F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of perfomance-based restricted stock units.